These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27562686)

  • 41. [11C]CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: a PET study in conscious monkeys.
    Hashimoto K; Nishiyama S; Ohba H; Matsuo M; Kobashi T; Takahagi M; Iyo M; Kitashoji T; Tsukada H
    PLoS One; 2008 Sep; 3(9):e3231. PubMed ID: 18800169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantification of alpha4beta2* nicotinic receptors in the rat brain with microPET and 2-[18F]F-A-85380.
    Vaupel DB; Stein EA; Mukhin AG
    Neuroimage; 2007 Feb; 34(4):1352-62. PubMed ID: 17187994
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro evaluation of nicotinic acetylcholine receptors with 2-[18F]F-A85380 in Parkinson's disease.
    Schmaljohann J; Gündisch D; Minnerop M; Bucerius J; Joe A; Reinhardt M; Guhlke S; Biersack HJ; Wüllner U
    Nucl Med Biol; 2006 Apr; 33(3):305-9. PubMed ID: 16631078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NIDA522131, a new radioligand for imaging extrathalamic nicotinic acetylcholine receptors: in vitro and in vivo evaluation.
    Chefer SI; Pavlova OA; Zhang Y; Vaupel DB; Kimes AS; Horti AG; Stein E; Mukhin AG
    J Neurochem; 2008 Jan; 104(2):306-15. PubMed ID: 17986233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 2-[18F]F-A-85380: a PET radioligand for alpha4beta2 nicotinic acetylcholine receptors.
    Chefer SI; Horti AG; Koren AO; Gündisch D; Links JM; Kurian V; Dannals RF; Mukhin AG; London ED
    Neuroreport; 1999 Sep; 10(13):2715-21. PubMed ID: 10511429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography.
    Horti AG; Gao Y; Kuwabara H; Dannals RF
    Life Sci; 2010 Apr; 86(15-16):575-84. PubMed ID: 19303028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism.
    Dubroff JG; Doot RK; Falcone M; Schnoll RA; Ray R; Tyndale RF; Brody AL; Hou C; Schmitz A; Lerman C
    J Nucl Med; 2015 Nov; 56(11):1724-9. PubMed ID: 26272810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography.
    Kendziorra K; Wolf H; Meyer PM; Barthel H; Hesse S; Becker GA; Luthardt J; Schildan A; Patt M; Sorger D; Seese A; Gertz HJ; Sabri O
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):515-25. PubMed ID: 21069319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [18F]FPhEP and [18F]F2PhEP, two new epibatidine-based radioligands: evaluation for imaging nicotinic acetylcholine receptors in baboon brain.
    Valette H; Dollé F; Saba W; Roger G; Hinnen F; Coulon C; Ottaviani M; Syrota A; Bottlaender M
    Synapse; 2007 Sep; 61(9):764-70. PubMed ID: 17568410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human brain imaging of α7 nAChR with [(18)F]ASEM: a new PET radiotracer for neuropsychiatry and determination of drug occupancy.
    Wong DF; Kuwabara H; Pomper M; Holt DP; Brasic JR; George N; Frolov B; Willis W; Gao Y; Valentine H; Nandi A; Gapasin L; Dannals RF; Horti AG
    Mol Imaging Biol; 2014 Oct; 16(5):730-8. PubMed ID: 25145965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Imaging nicotinic acetylcholine receptors with fluorine-18-FPH, an epibatidine analog.
    Villemagne VL; Horti A; Scheffel U; Ravert HT; Finley P; Clough DJ; London ED; Wagner HN; Dannals RF
    J Nucl Med; 1997 Nov; 38(11):1737-41. PubMed ID: 9374343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiation dosimetry of the α
    Kranz M; Sattler B; Tiepolt S; Wilke S; Deuther-Conrad W; Donat CK; Fischer S; Patt M; Schildan A; Patt J; Smits R; Hoepping A; Steinbach J; Sabri O; Brust P
    EJNMMI Phys; 2016 Dec; 3(1):25. PubMed ID: 27770429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease.
    Meyer PM; Strecker K; Kendziorra K; Becker G; Hesse S; Woelpl D; Hensel A; Patt M; Sorger D; Wegner F; Lobsien D; Barthel H; Brust P; Gertz HJ; Sabri O; Schwarz J
    Arch Gen Psychiatry; 2009 Aug; 66(8):866-77. PubMed ID: 19652126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of 5-(11)C-methyl-A-85380 as an imaging agent for PET investigations of brain nicotinic acetylcholine receptors.
    Iida Y; Ogawa M; Ueda M; Tominaga A; Kawashima H; Magata Y; Nishiyama S; Tsukada H; Mukai T; Saji H
    J Nucl Med; 2004 May; 45(5):878-84. PubMed ID: 15136639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2-18F-FA-85380.
    Mukhin AG; Kimes AS; Chefer SI; Matochik JA; Contoreggi CS; Horti AG; Vaupel DB; Pavlova O; Stein EA
    J Nucl Med; 2008 Oct; 49(10):1628-35. PubMed ID: 18794265
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preclinical and the first clinical studies on [11C]CHIBA-1001 for mapping alpha7 nicotinic receptors by positron emission tomography.
    Toyohara J; Sakata M; Wu J; Ishikawa M; Oda K; Ishii K; Iyo M; Hashimoto K; Ishiwata K
    Ann Nucl Med; 2009 May; 23(3):301-9. PubMed ID: 19337782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Derivatives of (-)-7-methyl-2-(5-(pyridinyl)pyridin-3-yl)-7-azabicyclo[2.2.1]heptane are potential ligands for positron emission tomography imaging of extrathalamic nicotinic acetylcholine receptors.
    Gao Y; Horti AG; Kuwabara H; Ravert HT; Hilton J; Holt DP; Kumar A; Alexander M; Endres CJ; Wong DF; Dannals RF
    J Med Chem; 2007 Aug; 50(16):3814-24. PubMed ID: 17629263
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography.
    Zhang Y; Pavlova OA; Chefer SI; Hall AW; Kurian V; Brown LL; Kimes AS; Mukhin AG; Horti AG
    J Med Chem; 2004 May; 47(10):2453-65. PubMed ID: 15115389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of fluorescence imaging probes for nicotinic acetylcholine α4β2
    Samra GK; Intskirveli I; Govind AP; Liang C; Lazar R; Green WN; Metherate R; Mukherjee J
    Bioorg Med Chem Lett; 2018 Feb; 28(3):371-377. PubMed ID: 29277457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LC-MS Supported Studies on the in Vitro Metabolism of both Enantiomers of Flubatine and the in Vivo Metabolism of (+)-[(18)F]Flubatine-A Positron Emission Tomography Radioligand for Imaging α4β2 Nicotinic Acetylcholine Receptors.
    Ludwig FA; Smits R; Fischer S; Donat CK; Hoepping A; Brust P; Steinbach J
    Molecules; 2016 Sep; 21(9):. PubMed ID: 27617996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.